Health
Synthetic Nanobodies Identified That Neutralize SARS-CoV-2 – Anti Aging News
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor…
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor on host cells; recent work published in Nature Communications suggests that a synthetic nanobody, sybodies, has been found that can neutralize SARS-CoV-2 constituting a potential treatment. The group of researchers are reporting the rapid isolation and characterization of nanobodies from a synthetic library called sybodies that target…
-
Noosa News18 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
General23 hours agoShored against our ruins
-
General24 hours agoUN special envoy Julie Bishop makes first trip to Myanmar after earthquake
-
General22 hours agoNZ PM wants united trade bloc-EU response to tariffs